Hikma Pharmaceuticals PLC (LON:HIK)

Hikma Pharmaceuticals Revenue

Hikma Pharmaceuticals had revenue of $1.66B USD in the half year ending June 30, 2025, with 16.19% growth. This brings the company's revenue in the last twelve months to $3.22B, up 6.60% year-over-year. In the year 2024, Hikma Pharmaceuticals had annual revenue of $3.13B with 8.77% growth.

• Revenue (ttm): $3.22B
• Revenue Growth: +6.60%
• P/S Ratio: 1.68
• Revenue / Employee: $338.53K
• Employees: 9,500
• Market Cap: 3.95B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.13B	252.00M	8.77%
Dec 31, 2023	2.88B	358.00M	14.22%
Dec 31, 2022	2.52B	-36.00M	-1.41%
Dec 31, 2021	2.55B	212.00M	9.06%
Dec 31, 2020	2.34B	134.00M	6.07%